EN-RAGE: A Novel Inflammatory Marker for Incident Coronary Heart Disease

Share this content:
EN-RAGE: A Novel Inflammatory Marker for Incident Coronary Heart Disease
EN-RAGE: A Novel Inflammatory Marker for Incident Coronary Heart Disease
Researchers investigated the association of 16 inflammatory biomarkers with the risk of CHD in a random subset of 839 CHD-free individuals in a prospective population-based cohort study. Among all inflammatory biomarkers, neutrophil-derived human s100a12 (extracellular newly identified receptor for advanced glycation end-products binding protein [EN-RAGE]) showed the strongest association with the risk of CHD (P value 2.0×10).
READ FULL ARTICLE From Ahajournals
Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

is free, fast, and customized just for you!




Already a member?

Sign In Now »